326 related articles for article (PubMed ID: 33635573)
1. Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support.
Numan L; Ramjankhan FZ; Oberski DL; Oerlemans MIFJ; Aarts E; Gianoli M; Van Der Heijden JJ; De Jonge N; Van Der Kaaij NP; Meuwese CL; Mokhles MM; Oppelaar AM; De Waal EEC; Asselbergs FW; Van Laake LW
ESC Heart Fail; 2021 Apr; 8(2):1596-1603. PubMed ID: 33635573
[TBL] [Abstract][Full Text] [Related]
2. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
[TBL] [Abstract][Full Text] [Related]
3. Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®.
Schramm R; Zittermann A; Morshuis M; Schoenbrodt M; von Roessing E; von Dossow V; Koster A; Fox H; Hakim-Meibodi K; Gummert JF
ESC Heart Fail; 2020 Jun; 7(3):908-914. PubMed ID: 32190985
[TBL] [Abstract][Full Text] [Related]
4. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
Florisson DS; Conte SM; De Bono JA; Newcomb AE
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
[TBL] [Abstract][Full Text] [Related]
5. Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry.
Francica A; Loforte A; Attisani M; Maiani M; Iacovoni A; Nisi T; Comisso M; Terzi A; De Bonis M; Vendramin I; Boffini M; Musumeci F; Luciani GB; Rinaldi M; Pacini D; Onorati F
Transpl Int; 2023; 36():11675. PubMed ID: 37727385
[TBL] [Abstract][Full Text] [Related]
6. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre.
Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E
Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34315231
[TBL] [Abstract][Full Text] [Related]
8. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
[TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34491776
[TBL] [Abstract][Full Text] [Related]
10. Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device.
Shin K; Cho WC; Shin N; Kim HR; Kim MS; Chung CH; Jung SH
J Chest Surg; 2024 Mar; 57(2):184-194. PubMed ID: 38360679
[TBL] [Abstract][Full Text] [Related]
11. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.
Chiang YP; Cox D; Schroder JN; Daneshmand MA; Blue LJ; Patel CB; DeVore AD; Bishawi M; Milano CA
J Card Surg; 2020 Feb; 35(2):383-389. PubMed ID: 31808964
[TBL] [Abstract][Full Text] [Related]
12. Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.
Suarez-Pierre A; Lui C; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
Ann Thorac Surg; 2019 Aug; 108(2):467-473. PubMed ID: 30880137
[TBL] [Abstract][Full Text] [Related]
13. Widening care gap in VAD therapy.
Conway J; Amdani S; Morales DLS; Lorts A; Rosenthal DN; Jacobs JP; Rossano J; Koehl D; Kirklin JK; Auerbach SR
J Heart Lung Transplant; 2023 Dec; 42(12):1710-1724. PubMed ID: 37591455
[TBL] [Abstract][Full Text] [Related]
14. Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices: the EUROMACS analysis.
Potapov EV; Nersesian G; Lewin D; Özbaran M; de By TMMH; Stein J; Pya Y; Gummert J; Ramjankhan F; Zembala MO; Damman K; Carrel T; Meyns B; Zimpfer D; Netuka I
Eur J Cardiothorac Surg; 2021 Sep; 60(3):579-587. PubMed ID: 33871594
[TBL] [Abstract][Full Text] [Related]
15. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
16. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
[TBL] [Abstract][Full Text] [Related]
17. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in Patients With HeartMate3 Versus HeartWare Ventricular Assist Device Implanted as Destination Therapy.
Wasilewski G; Kędziora A; Wiśniowska-Śmiałek S; Tomsia P; Kaleta M; Wierzbicki K
Transplant Proc; 2022 May; 54(4):1049-1053. PubMed ID: 35431097
[TBL] [Abstract][Full Text] [Related]
19. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of strokes associated with centrifugal flow left ventricular assist devices.
Inamullah O; Chiang YP; Bishawi M; Weiss M; Lutz MW; Blue LJ; Feng W; Milano CA; Luedke M; Husseini NE
Sci Rep; 2021 Jan; 11(1):1645. PubMed ID: 33462301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
